Recently, some biomarkers have been suggested for detecting the presence or absence of NASH by combining biochemical and clinical variables, such as sex, age, the BMI, serum levels of triglycerides, the AST/ALT ratio, AST, gamma-glutamyl transferase, homeostatic model assessment of insulin resistance, and cholesterol levels (6, 13). Here, GPT is linked to metabolic dysfunction-associated steatohepatitis.